Eye Movement Recording as an Early Differential Diagnostic Tool for Alzheimer/Depression (MOMAD)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2011 by Centre Hospitalier Universitaire de Besancon.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
Pr Pierre Vandel
Collaborators:
Psychology laboratory of Besançon EA 3188
Centre Hospitalier Universitaire Dijon
Hospital of Novillars
funding by French Hospital Progeram of Clinical Research (PHRC 2009-A00942-55)
Information provided by (Responsible Party):
Pr Pierre Vandel, Centre Hospitalier Universitaire de Besancon
ClinicalTrials.gov Identifier:
NCT01434940
First received: September 14, 2011
Last updated: September 15, 2011
Last verified: September 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The global aim of our study is to validate eye movement recording as an early differential diagnostic tool, in order to discriminate as early as possible between neurodegenerative dementias of Alzheimer type and depressive pseudodementias (DPD). The investigators want to put forward idiosyncratic oculomotor characteristics of Alzheimer's disease (AD) and DPD respectively. Eye movements are sensitive markers of neurological diseases and can be used in a variety of clinical neurological syndromes.
This study compares 3 groups of 98 patients: patients suffering of AD and DPD and healthy persons. The patients AD will be recruited in the Memory Centre of Resources and Research of Besançon and patients DPD will be selected in the psychiatric department of the University Hospital of Besançon. The control participants will be recruited from the entourage of researchers and patients. The selection of participants in the 3 different groups is based on clinical examinations in psychiatry and neurology and neuropsychological assessments. After giving informed consent, patients will be evaluated by a psychiatrist and a neuropsychologist. The complete assessment takes 150 minutes.
After having set up patients, eye movements will be recorded using video-oculography techniques. The following tasks are performed: the basic dynamic eye movements (latency, hypometric and hypermetric saccades, reaction time, saccade speed, accuracy, pupil diameter) will be evaluated by the pro-saccade, anti-saccade and predictive saccade tasks. The emotional connotation tasks will be assessed by scan of images pair with emotional connotation and portrait analysis. The assessment takes 30 minutes.
This study will include 3 groups:
- an Alzheimer group;
- a depressed group;
- a control group with healthy persons. The population of this study will be comprised of patients over age 60 with a visual acuity over 9/10, not diagnosed with eye disease and not neuropsychological sequelae that could disrupt the functioning oculomotor.
These people will be recruited on a voluntary basis, after notification and consent in the research center, the Psychiatry Clinical Department of the University Hospital of Besançon. This study was conducted over a period of 36 months.
| Condition | Intervention |
|---|---|
|
Alzheimer Disease Depression |
Other: Eye movements will be recorded using video-oculography techniques based on both the corneal reflection principle and an infra-red light beam |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Diagnostic |
| Official Title: | Early Oculomotor Markers in Alzheimer's Disease: Test of Predictive Value in the Differential Diagnosis Depression/Alzheimer |
Resource links provided by NLM:
Genetics Home Reference related topics:
Alzheimer disease
MedlinePlus related topics:
Alzheimer's Disease
U.S. FDA Resources
Further study details as provided by Centre Hospitalier Universitaire de Besancon:
Primary Outcome Measures:
- pro-saccade task [ Designated as safety issue: No ]The score differences to pro-saccade task between the 3 groups constitute the major research outcome measure used to measure the basic dynamic eye movements.
- anti-saccade task [ Designated as safety issue: No ]The score differences to anti-saccade task between the 3 groups consitute one of the major research outcome measure used to measure the basic dynamic eye movements.
- predictive saccade [ Designated as safety issue: No ]The score differences to predictive saccade tasks between the 3 groups constitute one of the major research outcome measure used to measure the basic dynamic eye movements
- scan of images pair with emotional connotation [ Designated as safety issue: No ]The score differences of scan of images pair with emotional connotation were used to evaluate the emotional tasks
- portrait analysis [ Designated as safety issue: No ]The score differences of portrait analysis were used to evaluate the emotional tasks
| Estimated Enrollment: | 288 |
| Study Start Date: | April 2010 |
| Estimated Study Completion Date: | April 2013 |
| Estimated Primary Completion Date: | April 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Alzheimer
Patients suffering of Alzheimer disease
|
Other: Eye movements will be recorded using video-oculography techniques based on both the corneal reflection principle and an infra-red light beam
. The system named H6-HSCN by Applied Science Laboratories (ASL®) helps keep the patient's head fixed on a support, important for the elderly population. This system allows to capture data with good temporal resolution (sampling at 360Hz) and good spatial resolution (accuracy of 0.1° of visual angle) at a distance of about 70 cm from the screen test with a visual angle of 32.6°. Results will be processed with ASL Result Software.
|
|
Experimental: Depression
Patients suffering from depression
|
Other: Eye movements will be recorded using video-oculography techniques based on both the corneal reflection principle and an infra-red light beam
. The system named H6-HSCN by Applied Science Laboratories (ASL®) helps keep the patient's head fixed on a support, important for the elderly population. This system allows to capture data with good temporal resolution (sampling at 360Hz) and good spatial resolution (accuracy of 0.1° of visual angle) at a distance of about 70 cm from the screen test with a visual angle of 32.6°. Results will be processed with ASL Result Software.
|
|
Experimental: Healthy
Healthy volunteers
|
Other: Eye movements will be recorded using video-oculography techniques based on both the corneal reflection principle and an infra-red light beam
. The system named H6-HSCN by Applied Science Laboratories (ASL®) helps keep the patient's head fixed on a support, important for the elderly population. This system allows to capture data with good temporal resolution (sampling at 360Hz) and good spatial resolution (accuracy of 0.1° of visual angle) at a distance of about 70 cm from the screen test with a visual angle of 32.6°. Results will be processed with ASL Result Software.
|
Eligibility| Ages Eligible for Study: | 60 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- subject whose visual acuity > 9/10
- subject without a diagnosis of eye disease
- subject without a neuropsychological sequelae
- for depressed patients :subject with a diagnosis of depression confirmed by a psychiatric evaluation and MADRS (Montgomery and Asberg Depression Rating Scale) score >25 and without cognitive impairment or any other psychiatric pathology and MMSE (Mini Mental State Examination)≥18 and without symptoms of AD
- for Alzheimer patients :subject with AD diagnosed according to NINCDS-ADRDA (National Institute of Neurological and Communicative Disorders and Stroke -Alzheimer's Disease and Related Disorders Association) criteria and MMSE ≥18 and without psychiatric disorder and MADRS score < 25
- for control patients : subject without AD, depression or any other psychiatric condition identified by the diagnostic criteria or cognitive disorders and MADRS score <25 and MMSE > 20
Exclusion Criteria:
- subject age under 60
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01434940
Please refer to this study by its ClinicalTrials.gov identifier: NCT01434940
Contacts
| Contact: Pierre VANDEL, Prof | +33381218073 | pierre.vandel@univ-fcomte.fr |
Locations
| France | |
| Univserity Hospital of Besançon - Psychiatry Department | Recruiting |
| Besançon, France, 25000 | |
| Contact: Julie MONNIN, PhD +33381218543 jmonnin@chu-besancon.fr | |
| Contact: Magali NICOLIER, PhD +3381218073 mnicolier@chu-besancon.fr | |
| Principal Investigator: Pierre VANDEL, PUPH | |
Sponsors and Collaborators
Pr Pierre Vandel
Psychology laboratory of Besançon EA 3188
Centre Hospitalier Universitaire Dijon
Hospital of Novillars
funding by French Hospital Progeram of Clinical Research (PHRC 2009-A00942-55)
Investigators
| Principal Investigator: | Pierre VANDEL, Prof | Centre Hospitalier Universitaire de Besancon |
More Information
No publications provided
| Responsible Party: | Pr Pierre Vandel, PU PH, Centre Hospitalier Universitaire de Besancon |
| ClinicalTrials.gov Identifier: | NCT01434940 History of Changes |
| Other Study ID Numbers: | MOMAD |
| Study First Received: | September 14, 2011 |
| Last Updated: | September 15, 2011 |
| Health Authority: | France: Committee for the Protection of Personnes France: Direction Générale de la Santé France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis) |
Keywords provided by Centre Hospitalier Universitaire de Besancon:
|
Alzheimer disease Depression Differential diagnosis Eye movement |
Additional relevant MeSH terms:
|
Alzheimer Disease Depression Depressive Disorder Behavioral Symptoms Brain Diseases Central Nervous System Diseases Delirium, Dementia, Amnestic, Cognitive Disorders |
Dementia Mental Disorders Mood Disorders Nervous System Diseases Neurodegenerative Diseases Tauopathies |
ClinicalTrials.gov processed this record on March 03, 2015